Loading fund information
Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
The fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 63 positions. The ten largest identified positions carry 54.1% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | BeOne Medicines AG | — | Hong Kong | 8.84% | $6.29M |
| 2 | INNOVENT BIOLOGICS, INC. | — | Hong Kong | 8.79% | $6.26M |
| 3 | WUXI BIOLOGICS (CAYMAN) INC. | — | Hong Kong | 7.51% | $5.35M |
| 4 | WuXi AppTec Co., Ltd. | — | China | 5.78% | $4.12M |
| 5 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | — | China | 4.58% | $3.26M |
| 6 | Shenzhen Mindray Bio-Medical Electronics Co Ltd | — | China | 4.27% | $3.04M |
| 7 | Akeso Inc | — | Hong Kong | 3.72% | $2.64M |
| 8 | CSPC PHARMACEUTICAL GROUP LIMITED | — | Hong Kong | 3.67% | $2.62M |
Source: SEC filings. Information and analytics, not investment advice.
| 9 |
| Invesco Government & Agency Portfolio |
| — |
| United States |
| 3.54% |
| $2.52M |
| 10 | SINO BIOPHARMACEUTICAL LIMITED | — | Hong Kong | 3.38% | $2.41M |
| 11 | WuXi AppTec Co., Ltd. | — | Hong Kong | 3.35% | $2.38M |
| 12 | HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | — | Hong Kong | 2.85% | $2.03M |
| 13 | 3SBio Inc. | — | Hong Kong | 2.48% | $1.77M |
| 14 | YUNNAN BAIYAO GROUP CO., LTD | — | China | 2.30% | $1.64M |
| 15 | Shanghai United Imaging Healthcare Co., Ltd. | — | China | 2.27% | $1.61M |
| 16 | Aier Eye Hospital Group Co., Ltd. | — | China | 2.09% | $1.49M |
| 17 | Sichuan Biokin Pharmaceutical Co Ltd | — | China | 1.96% | $1.40M |
| 18 | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | — | Hong Kong | 1.85% | $1.31M |
| 19 | ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | — | China | 1.73% | $1.23M |
| 20 | SINOPHARM GROUP CO. LTD. | — | Hong Kong | 1.67% | $1.19M |
| 21 | Sichuan Kelun Pharmaceutical Co., Ltd. | — | China | 1.54% | $1.10M |
| 22 | Haisco Pharmaceutical Group Co., Ltd. | — | China | 1.52% | $1.08M |
| 23 | HUADONG MEDICINE CO., LTD | — | China | 1.36% | $969.12K |
| 24 | WuXi XDC Cayman Inc | — | Hong Kong | 1.35% | $963.92K |
| 25 | Shanghai Allist Pharmaceuticals Co Ltd | — | China | 1.33% | $954.42K |